Emergent BioSolutions, a prominent biopharmaceutical company, navigates a multi-year business transformation focused on strengthening its core operations and financial health. This involves integrating specific manufacturing technologies and optimizing its supply chain and internal processes to ensure robust product delivery. The company emphasizes continuous improvement and targeted investments within its established product portfolio and operational framework.
This strategic shift creates critical dependencies on upgraded manufacturing systems, standardized operational data, and agile distribution networks. The transformation introduces potential points of breakdown in data flow, system integration, and workflow execution if not meticulously managed. This page analyzes Emergent BioSolutions' key initiatives, specific operational challenges, and areas creating sales opportunities for solution providers.
Emergent BioSolutions Snapshot
- Headquarters: Gaithersburg, Maryland, U.S.
- Number of employees: 900 employees
- Public or private: Public
- Business model: Both (B2B & B2C)
- Website: http://www.emergentbiosolutions.com
Emergent BioSolutions ICP and Buying Roles
Emergent BioSolutions targets specialized biopharmaceutical companies with complex manufacturing needs and government entities requiring medical countermeasures. They also serve public health organizations and commercial channels for overdose reversal products.
Who drives buying decisions
- Chief Operating Officer → Oversees operational efficiency and manufacturing strategy.
- Head of Manufacturing → Manages adoption of new manufacturing technologies and processes.
- VP, Supply Chain → Directs logistics and distribution network optimization.
- Head of Quality Assurance → Ensures compliance and documentation standards.
- Chief Information Officer → Manages enterprise systems and data integrity.
Key Digital Transformation Initiatives at Emergent BioSolutions (At a Glance)
- Integrating aseptic filling workcells into product manufacturing.
- Expanding distribution infrastructure for product delivery networks.
- Reengineering quality assurance workflows for documentation and SOPs.
- Consolidating manufacturing facilities to streamline operational processes.
Where Emergent BioSolutions’s Digital Transformation Creates Sales Opportunities
| Vendor Type | Where to Sell (DT Initiative + Challenge) | Buyer / Owner | Solution Approach |
|---|---|---|---|
| Manufacturing Automation Platforms | Aseptic Manufacturing Technology Adoption: manual adjustments occur during fill-finish operations. | Head of Manufacturing, Process Engineer | Automate precise parameter control within manufacturing workcells. |
| Aseptic Manufacturing Technology Adoption: deviations in sterility protocols require human verification. | Head of Quality Assurance, Plant Manager | Enforce real-time compliance checks within aseptic environments. | |
| Enterprise Operational Process Streamlining: disparate systems delay production line restarts. | Operations Director, IT Director | Route automated commands to restart connected manufacturing equipment. | |
| Supply Chain & Logistics Systems | Supply Chain Network Optimization: inventory counts do not align across new distribution centers. | VP, Supply Chain, Logistics Manager | Validate stock levels across warehouse management systems. |
| Supply Chain Network Optimization: online order data fails to synchronize with fulfillment systems. | Head of E-commerce, Supply Chain Manager | Prevent data entry errors between sales and inventory platforms. | |
| Enterprise Operational Process Streamlining: material tracking systems do not update across consolidated facilities. | VP, Supply Chain, Operations Manager | Detect location discrepancies for raw materials and finished goods. | |
| Quality & Compliance Software | Quality Assurance Process Documentation: outdated standard operating procedures circulate between teams. | Head of Quality Assurance, Compliance Officer | Standardize document versions across regulated departments. |
| Quality Assurance Process Documentation: audit trails lack complete data for regulatory submissions. | Quality Director, Regulatory Affairs Lead | Enforce comprehensive data capture for all workflow changes. | |
| Enterprise Resource Planning (ERP) | Enterprise Operational Process Streamlining: financial data inconsistencies appear after facility consolidation. | CFO, Head of Finance, CIO | Detect mismatching transaction entries between financial modules. |
| Enterprise Operational Process Streamlining: production scheduling conflicts arise from fragmented system data. | Operations Director, Production Planner | Validate resource availability across integrated planning modules. |
Identify when companies like Emergent BioSolutions are in-market for your solutions.
Spot buying signals, find the right prospects, enrich your data, and reach out with relevant messaging at the right time.
What makes this Emergent BioSolutions’s digital transformation unique
Emergent BioSolutions focuses its digital transformation efforts on refining existing operational capabilities rather than adopting entirely new digital technologies like AI or IoT. This approach prioritizes stability and cost management within its biopharmaceutical manufacturing and distribution networks. Their transformation heavily depends on rigorous compliance and data integrity across specialized production processes and government contracts. The company's emphasis on consolidating physical operations also dictates the nature of its digital initiatives, driving integration requirements for streamlined workflows.
Emergent BioSolutions’s Digital Transformation: Operational Breakdown
DT Initiative 1: Aseptic Manufacturing Technology Adoption
What the company is doing
Emergent BioSolutions integrates Cytiva's SA25 aseptic filling workcell into its manufacturing lines. This change supports product quality and sterility assurance in vaccine production. The company implements automation within its fill-finish operations.
Who owns this
- Head of Manufacturing
- Process Engineer
- Plant Manager
Where It Fails
- Aseptic filling processes generate deviations when manual calibration steps occur.
- Production line equipment does not communicate process parameters to quality systems.
- Sterility validation records contain incomplete data for regulatory review.
- Automated sequencing blocks entire batches when individual units fail inspection.
Talk track
Noticed Emergent BioSolutions is adopting advanced aseptic manufacturing technology. Been looking at how some biopharma teams are automating real-time parameter control instead of relying on manual checks, can share what’s working if useful.
DT Initiative 2: Supply Chain Network Optimization
What the company is doing
Emergent BioSolutions expands its NARCANDirect online distribution network. The company establishes new physical distribution centers, such as the West Coast facility. This initiative strengthens product accessibility and delivery.
Who owns this
- VP, Supply Chain
- Logistics Manager
- Head of E-commerce
Where It Fails
- Inventory records show discrepancies between the new West Coast facility and central systems.
- Online order placements do not transfer accurately to warehouse picking workflows.
- Shipping delays occur when direct-to-consumer order data fails to integrate with carrier platforms.
- Product traceability information lacks updates across different distribution points.
Talk track
Looks like Emergent BioSolutions is optimizing its supply chain network. Been seeing how some organizations are validating real-time inventory synchronization instead of reconciling data manually, happy to share what we’re seeing.
DT Initiative 3: Quality Assurance Process Documentation
What the company is doing
Emergent BioSolutions reengineers its Quality Assurance workflows. The team focuses on creating user-focused process documentation and Standard Operating Procedures (SOPs). This involves applying Information Mapping principles to content standards.
Who owns this
- Head of Quality Assurance
- Compliance Officer
- Quality Director
Where It Fails
- Updated SOPs do not propagate across all relevant departments simultaneously.
- Version control conflicts appear in critical quality documentation systems.
- Training records for new procedures fail to link with employee compliance profiles.
- Audit preparation requires manual compilation of disparate documentation sources.
Talk track
Saw Emergent BioSolutions is reengineering quality assurance documentation. Been looking at how some regulatory teams are enforcing automated version control instead of managing documents manually, can share what’s working if useful.
DT Initiative 4: Enterprise Operational Process Streamlining
What the company is doing
Emergent BioSolutions consolidates manufacturing facilities and restructures its workforce. The company aims to improve operational performance and profitability. This multi-year plan streamlines underlying operational processes.
Who owns this
- Chief Operating Officer
- IT Director
- CFO
Where It Fails
- Financial reporting systems display inconsistent data after facility closures.
- Inter-departmental approvals for budget reallocations stall in fragmented systems.
- Employee access permissions do not update consistently across all enterprise platforms following restructuring.
- Asset tracking systems contain outdated location data for transferred equipment.
Talk track
Noticed Emergent BioSolutions is streamlining enterprise operational processes. Been looking at how some companies are standardizing data synchronization across financial systems instead of conducting manual reconciliation, happy to share what we’re seeing.
Who Should Target Emergent BioSolutions Right Now
This account is relevant for:
- Manufacturing Execution System (MES) vendors
- Warehouse Management System (WMS) providers
- Document control and Quality Management System (QMS) platforms
- Supply chain visibility and data integration solutions
- Enterprise Resource Planning (ERP) consulting and optimization firms
Not a fit for:
- AI/ML platforms for predictive analytics (explicitly not their focus)
- Generic marketing automation tools
- HR talent acquisition platforms
- Basic IT infrastructure providers without specialized biotech focus
When Emergent BioSolutions Is Worth Prioritizing
Prioritize if:
- You sell solutions that prevent manual adjustments in automated manufacturing workcells.
- You sell platforms that validate real-time inventory synchronization across diverse distribution networks.
- You sell tools that enforce version control and automated propagation of quality documentation.
- You sell systems that detect data inconsistencies between financial modules after operational restructuring.
Deprioritize if:
- Your solution primarily focuses on broad AI adoption or IoT implementation.
- Your product is limited to basic process management without system-level integration.
- Your offering does not directly address specific manufacturing, supply chain, or quality compliance failures.
Who Can Sell to Emergent BioSolutions Right Now
Manufacturing Automation Platforms
Rockwell Automation - This company provides industrial automation and information solutions for manufacturing operations.
Why they are relevant: Emergent BioSolutions integrates new aseptic filling workcells, which require precise parameter control. Rockwell Automation can enforce automated real-time monitoring and control within these manufacturing workcells, preventing manual adjustments and ensuring process consistency.
Siemens Digital Industries Software - This company offers software for product lifecycle management and manufacturing operations management.
Why they are relevant: Emergent BioSolutions implements automation in its fill-finish processes, which demands seamless data flow between equipment and quality systems. Siemens Digital Industries Software can integrate production line equipment data directly into quality systems, detecting deviations and ensuring data integrity for audit trails.
Supply Chain Management Solutions
Blue Yonder - This company provides cloud-based supply chain management software that plans and executes logistics.
Why they are relevant: Emergent BioSolutions expands its distribution network, leading to potential inventory count discrepancies. Blue Yonder can validate stock levels across all warehouse management systems, ensuring accurate inventory records for improved planning.
Manhattan Associates - This company offers omnichannel commerce and supply chain solutions, including warehouse and transportation management.
Why they are relevant: Emergent BioSolutions expands its NARCANDirect online network, causing online order data to sometimes fail to synchronize with fulfillment systems. Manhattan Associates can prevent data entry errors and maintain real-time integration between online sales and inventory platforms, streamlining order processing.
Quality Management System (QMS) Providers
Veeva Systems - This company provides cloud-based software for the global life sciences industry, including quality and content management.
Why they are relevant: Emergent BioSolutions reengineers quality assurance workflows, facing challenges with outdated SOPs and version control. Veeva Systems can standardize document versions across regulated departments and enforce automated propagation of updated procedures, ensuring compliance and data consistency.
MasterControl - This company offers quality management system software designed specifically for regulated industries.
Why they are relevant: Emergent BioSolutions struggles with incomplete data in audit trails for regulatory submissions. MasterControl can enforce comprehensive data capture for all workflow changes and link training records to employee compliance profiles, ensuring complete and accurate documentation for audits.
Enterprise Resource Planning (ERP) Integrators
SAP (through partners) - This company provides enterprise software to manage business operations and customer relations.
Why they are relevant: Emergent BioSolutions consolidates facilities, leading to financial reporting inconsistencies. SAP, through specialized integrators, can detect mismatched transaction entries between financial modules and ensure consistent data following facility consolidation, strengthening financial integrity.
Oracle (through partners) - This company offers a suite of integrated applications for business operations, including ERP.
Why they are relevant: Emergent BioSolutions experiences production scheduling conflicts due to fragmented system data from operational streamlining. Oracle, via implementation partners, can validate resource availability across integrated planning modules, resolving scheduling conflicts and improving operational efficiency.
Final Take
Emergent BioSolutions scales its core biopharmaceutical manufacturing and distribution capabilities. Breakdowns are visible in manual manufacturing steps, inconsistent supply chain data synchronization, and fragmented quality documentation. This account is a strong fit when selling solutions that directly address these specific operational failures within regulated biopharmaceutical environments.
Identify buying signals from digital transformation at your target companies and find those already in-market.
Find the right contacts and use tailored messages to reach out with context.